Found 2030 results for "cancer"
A single protein appears to sit at the intersection of three of melanoma's most dangerous properties — its ability to remodel its physical environment…
Epstein-Barr virus quietly persists in nearly all adults, yet for roughly 200,000 people annually it triggers cancers including lymphomas and nasopharyngeal…
Understanding how cells decide between a quiet death and an inflammatory one has enormous implications for cancer therapy, autoimmune disease, and age-related…
Most inflammatory research focuses on external threats — viruses, bacteria, environmental toxins — yet some of the most consequential triggers of chronic…
A conceptual shift in how we classify disease burden may fundamentally alter where global health investment flows — and how much return humanity can expect…
Vitamin D's role in cancer biology has long been theorized but frustratingly difficult to confirm in rigorous clinical settings. A new randomized trial…
For patients facing metastatic colorectal cancer — one of the deadliest and most treatment-resistant malignancies — the possibility that a widely available…
Cancer cachexia — the devastating muscle-wasting syndrome affecting up to 80% of advanced cancer patients — remains one of oncology's most treatment-resistant…
For the millions of adults navigating a cancer diagnosis or monitoring emerging oncology options, checkpoint inhibitor therapy has become one of the most…
For decades, the holy grail of autoimmune disease management has been teaching the immune system to stand down selectively — without broadly suppressing…
Psychological distress following a breast cancer diagnosis is not a peripheral concern — it shapes quality of life, treatment adherence, and long-term…
A fundamental assumption in targeted protein degradation has been that the target protein must display a recognizable degron — a structural tag that flags it…
Trabeculectomy's gold-standard adjunct mitomycin C (MMC) kills most fibroblasts to prevent scarring—but single-cell RNA sequencing of postoperative glaucoma…
Using the INK-ATTAC transgenic mouse model, selective elimination of p16Ink4a-positive senescent cells at 4 months post-irradiation — but not at 1 month…
Grape peel-derived exosome-like nanoparticles (GELNs) — isolated via ultracentrifugation — effectively shuttle resveratrol (RSV) into HNE-1 nasopharyngeal…
A troubling epidemiological inversion is underway in gastrointestinal oncology: cancers of the colon, rectum, stomach, and other GI sites are declining in…
Triple-negative breast cancer remains one of oncology's most difficult targets precisely because it lacks the molecular handles that make other breast cancers…
For cancer immunotherapy to work better, the tumor microenvironment must sustain organized immune activity — not just recruit immune cells, but keep them…
For the millions of women told their mammograms are limited by dense breast tissue, the choice of supplemental screening technology is not merely procedural…
Colorectal cancer's notorious resistance to immunotherapy has long frustrated clinicians, but a newly characterized molecular switch may explain why…